Información de la revista
Lo más leído
8205
Evolving portal hypertension through Baveno VII recommendationsManuel Mendizabal, Guilherme Grossi Lopes Cançado, Agustín Albillos
Ann Hepatol. 2024;29:101180
8205
Acceso a texto completo
5802
Administration of silymarin in NAFLD/NASH: A systematic review and meta-analysisShudi Li, Fei Duan, Suling Li, Baoping Lu
Ann Hepatol. 2024;29:101174
5802
Acceso a texto completo
5426
From NAFLD to MASLD: When metabolic comorbidity mattersShan Hong, Lei Sun, Yiwei Hao, Ping Li, Yuling Zhou, Xiuxia Liang, Julong Hu, Hongshan Wei
Ann Hepatol. 2024;29:101281
5426
Acceso a texto completo
5022
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, ... NAFLD Nomenclature consensus group
Ann Hepatol. 2024;29:101133
5022
Acceso a texto completo
4451
Alcohol-associated liver disease: Epidemiology and managementHelena Hernández-Évole, Natalia Jiménez-Esquivel, Elisa Pose, Ramón Bataller
Ann Hepatol. 2024;29:101162
4451
Acceso a texto completo
3806
Why a pinch of zinc in liver disease mattersKurt Grüngreiff, Dirk Reinhold, Wolfgang Maret
Ann Hepatol. 2024;29:101152
3806
Acceso a texto completo
3481
Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cellsShuguang Pan, Ying Hu, Lang Gan, Jiejuan Lai, Ping Zheng, YuJun Zhang, Ling Shuai, Yan Jiang, ... Yu He
Ann Hepatol. 2024;29:101279
3481
Acceso a texto completo
3410
Pathophysiology of ascites: The importance of the intestine. A surgical contribution to the understanding of a medical problemGabriel E. Gondolesi, Carolina Rumbo, Leonardo Montes, Lucia Novellis, Diego Ramisch, Ariel Riquelme Henríquez, Mariana Ortega, Federico Viano, ... Héctor Solar
Ann Hepatol. 2024;29:101498
3410
Acceso a texto completo
3235
MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney diseaseZiyan Pan, Moutaz Derbala, Khalid AlNaamani, Hasmik Ghazinian, Jian-Gao Fan, Mohammed Eslam
Ann Hepatol. 2024;29:101512
3235
Acceso a texto completo
3136
Alcohol-related liver disease: A global perspectiveGraciela Elia Castro Narro, Luis Antonio Díaz, Eric Kauffman Ortega, María Fernanda Bautista Garín, Eira Cerda Reyes, Pindaro Sebastian Martinez Delfin, Juan Pablo Arab, Ramón Bataller
Ann Hepatol. 2024;29:101499
3136
Acceso a texto completo
2955
The burden of liver disease in Latin AmericaLuis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese
Ann Hepatol. 2024;29:101175
2955
Acceso a texto completo
2458
Hepatic Steatosis Index (HSI): A Valuable Biomarker in Subjects with Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Bryan A. Priego-Parra, Arturo Triana-Romero, Génesis P. Martínez-Pérez, Sara A. Reyes-Diaz, Héctor R. Ordaz-Alvarez, Raúl Bernal-Reyes, María E. Icaza-Chávez, Sophia E. Martínez-Vázquez, ... José M. Remes-Troche
Ann Hepatol. 2024;29 Supl 2:101292.4
2458
Acceso a texto completo
2318
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFTJeremy Lee, Christopher J. Byrne, Paul N. Brennan, Iain MacPherson, Eleanor Dow, John F. Dillon
Ann Hepatol. 2024;29:101280
2318
Acceso a texto completo
2248
Schistosomiasis: A neglected cause of liver disease in the PhilippinesAlexander M. Sy
Ann Hepatol. 2024;29:101166
2248
Acceso a texto completo
1975
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.Federico Piñero, Ezequiel Mauro, Paola Casciato, Alejandro Forner
Ann Hepatol. 2024;29:101185
1975
Acceso a texto completo
1750
Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma careInah Marie C. Aquino, Devis Pascut
Ann Hepatol. 2024;29:101176
1750
Acceso a texto completo
1719
Prevalence of occult hepatitis B virus infection and characterisation of hepatitis B surface antigen mutants among adults in western CroatiaMarina Bubonja-Šonje, Dolores Peruč, Maja Abram, Bojana Mohar-Vitezić
Ann Hepatol. 2024;29:101156
1719
Acceso a texto completo
1621
A clinical review of congenital hepatic fibrosis diagnosed in adulthood: presentation, complications, and outcomesLauren Loeb, Jason Lewis, Zhongwei Peng, Michael G. Heckman, Raouf Nakhleh, Andrew P. Keaveny
Ann Hepatol. 2024;29:101164
1621
Acceso a texto completo
1603
From NAFLD to MASLD: Promise and pitfalls of a new definitionKenneth Cusi, Zobair Younossi, Michael Roden
Ann Hepatol. 2024;29:101179
1603
Acceso a texto completo
1559
Palliative care and end stage liver disease: A cohort analysis of palliative care use and factors associated with referralHugo M Oliveira, Helena Pessegueiro Miranda, Francisca Rego, Rui Nunes
Ann Hepatol. 2024;29:101518
1559
Acceso a texto completo